Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q1 FY20 Earnings Presentation
16 slides from Aarti Industries's earnings presentation, Aug 14, 2019
Slide 1: Cover letter to stock exchanges
AARTI @l INDUSTRIES LIMITED Ref. No: ArL lB-39 I 2OL9 I 43L August L4r 2OL9 To, To, Listing/ ComPliance DePartment Listing/ ComPliance DePartmen t BSE LTD. National Stock Exchange of Pin;oze Jeej eebhoY Towers, India Limited Dalal Street, "Bxchange Plaza", Plot No' Cl l, Mumbai - 400 001 . G Block B
Slide 2: Q1 FY20 Results Presentation
AARTI INDUSTRIES LIMITED Q1 FY20 Results Presentation August 2019
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Agenda
Agenda 1 | At a glance 2 | Quarterly performance 3
Slide 5: Company Overview
Company Overview Overview Key Metrics A leading Speciality Chemicals company in Benzene based derivatives with integrated operations and high level of cost optimization Established by first generation technocrats in 1984 200+ 400+ 700+ Global Domestic Pharma operations spanning APIs, intermedi
Slide 6: Key Strengths
Key Strengths • Global Player in Benzene based Derivatives with Integrated Operations o Strong/Leadership position in key products and processes o Integrated operations across product chain of Benzene and Toluene o Ability to effectively use co-products and generate value-added products • Well Diver
Slide 7: Agenda
Agenda 1 | At a glance 2 | Quarterly performance 6
Slide 8: Chairman’s Message
Chairman’s Message Commenting on the performance for Q1 FY20, Mr. Rajendra Gogri – Chairman & MD at Aarti Industries Ltd. said, “We have started FY20 on a strong note, recording profit after tax of Rs. 137 crore on standalone basis in this current challenging environment. I am pleased to share that
Slide 9: Q1 FY20 Highlights
Q1 FY20 Highlights Financial & Capex Recorded highest ever quarterly PAT of Rs 137 crore, representing a significant growth of 54% YoY EBIT margin expands 420 bps YoY to 18.1% in Q1 FY20 As part of its strategy to safeguard business against currency risks, the Company had entered into forward
Slide 10: Q1 FY20 P&L (Standalone)
Q1 FY20 P&L (Standalone) Y-o-Y Particulars Q1 FY20 Q1 FY19 Growth Q4 FY19 (Rs. Crore) (%) Gross Income from 1,086.1 1,078.5 0.7% 1,211.4 Operations • Adjusted for the demerger of the HPC business, Exports 454.9 396.1 14.8% 496.9 revenue up 8.8% YoY % of Total Income 41.9% 36.7% 5.2% 41.0% • Margin i
Slide 11: Q1 FY20 – Speciality Chemicals (Standalone)
Q1 FY20 – Speciality Chemicals (Standalone) Revenue 895 Specialty Chemicals revenue up 6% YoY, despite decrease in raw material prices. 848 Net of RM price changes, the Revenue growth on YOY basis is 9.4% Absolute EBIT expands 36% YoY while EBIT Q1 FY19 Q1 FY20 margins expand to 22.5% in Q1 FY
Slide 12: Q1 FY20 – Pharma (Standalone)
Q1 FY20 – Pharma (Standalone) Pharma 191 150 Pharma business delivered strong revenue growth of 28% YoY. Highest ever EBIT reported for the Pharma Q1 FY19 Q1 FY20 Segment. Diversified contribution from domestic, regulated and non-regulated markets Pharma Focusing on off‐patented generics in
Slide 13: Revenue Performance (Consolidated)
Revenue Performance (Consolidated) Revenue Export 2500 CAGR: 13% Deep engagement with Operating revenues have 1,977 grown on the back of 1,596 2000 global customers in 1,449 1,431 1,523 strong volume growth in 4,705 Speciality chemicals and 1500 key business segments and 3,806 pharma. In addition, p
Slide 14: EBIT Performance (Consolidated)
EBIT Performance (Consolidated) EBIT Higher growth relative to CAGR: 21% 932 revenue highlights value addition delivered by AIL 615 663 542 447 207 FY15 FY16 FY17 FY18 FY19 Q1 FY20 Speciality Chemicals Pharmacuticals CAGR: 19% 819 CAGR: 33% 113 504 566 581 79 408 213 36 39 48 32 FY15 FY16 FY17 FY18
Slide 15: Contact Us
Contact Us For further information please log on to www.aarti-industries.com or contact: Mr. Chetan Gandhi / Mr. Raj Sarraf Aarti Industries Limited Tel: +91 22 6797 6666 Email: info@aarti-industries.com Shiv Muttoo / Varun Divadkar CDR India Tel: +91 98335 57572 / 97637 02204 Email: shiv@cdr-india.
Slide 16: Thank You
Thank You 15